Home - Products - Others - Other Targets - petunidin-3-O-(6-O-p-coumaroyl)glucoside-5-O-diglucoside

petunidin-3-O-(6-O-p-coumaroyl)glucoside-5-O-diglucoside

CAS No. 1063818-55-2

petunidin-3-O-(6-O-p-coumaroyl)glucoside-5-O-diglucoside( ——— )

Catalog No. M39771 CAS No. 1063818-55-2

petunidin-3-O-(6"-O-p-coumaroyl)glucoside-5-O-diglucoside

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
25MG Get Quote Get Quote
50MG Get Quote Get Quote
100MG Get Quote Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    petunidin-3-O-(6-O-p-coumaroyl)glucoside-5-O-diglucoside
  • Note
    Research use only, not for human use.
  • Brief Description
    petunidin-3-O-(6"-O-p-coumaroyl)glucoside-5-O-diglucoside
  • Description
    petunidin-3-O-(6"-O-p-coumaroyl)glucoside-5-O-diglucoside
  • In Vitro
    ———
  • In Vivo
    ———
  • Synonyms
    ———
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    ———
  • Research Area
    ———
  • Indication
    ———

Chemical Information

  • CAS Number
    1063818-55-2
  • Formula Weight
    ———
  • Molecular Formula
    ———
  • Purity
    >98% (HPLC)
  • Solubility
    ———
  • SMILES
    ———
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • Cinepazide maleate

    A cerebral vasodilator that acts as a calcium blocker; protect neuronal cells against OGD injury by suppressing OGD-induced oxidative stress and preserving mitochondrial functions.

  • Dihydronarwedine

    Dihydronarwedine (Lycoraminone) is the alkaloid. Dihydronarwedine inhibits 39% activity of glycogen synthase kinase-3β (GSK-3β) at a concentration of 10 μM.

  • CPSI-1306

    (±)-CPSI-1306 is a macrophage migration inhibitory factor (MIF) antagonist and can be used in studies about non-insulin-dependent diabetes mellitus (NIDDM) and the prevention of the deleterious cutaneous effects of acute and chronic UVB exposure.